Iqbal J. Hussain - Feb 1, 2025 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role: General Counsel
Signature: /s/ Gregory Weinhoff, attorney-in-fact
Stock symbol: CNTA
Transactions as of: Feb 1, 2025
Transactions value $: -$217,913
Form type: 4
Date filed: 2/4/2025, 04:56 PM
Previous filing: Jan 17, 2025
Next filing: Feb 19, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNTA	Ordinary Shares	Tax liability	-$218K	-12.9K	-10.89%	$16.92	105K	Feb 1, 2025	Direct	F1, F2
holding	CNTA	Ordinary Shares						5.5K	Feb 1, 2025	By spouse	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNTA	Share Option (right to buy)	Award	$0	+175K		$0.00	175K	Feb 3, 2025	Ordinary Shares	175K	$16.90	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2	Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
F3	1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 3, 2025.